VACCITECH ONCOLOGY LIMITED
Get an alert when VACCITECH ONCOLOGY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£342K
-65.2% vs 2024
Net assets
£259K
-27.5% vs 2024
Employees
0
Average over period
Profit before tax
-£96K
+77% vs 2024
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | -£423,000 | -£96,000 | +77.3% | |
| Profit before tax | -£417,000 | -£96,000 | +77% | |
| Net profit | -£396,000 | -£98,000 | +75.3% | |
| Cash | £983,000 | £342,000 | -65.2% | |
| Total assets less current liabilities | £357,000 | £259,000 | -27.5% | |
| Net assets | £357,000 | £259,000 | -27.5% | |
| Equity | £357,000 | £259,000 | -27.5% | |
| Average employees | 0 | 0 | — | |
| Wages | — | — | — | |
| Directors' remuneration | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Return on capital employed | -118.5% | -37.1% | |
| Current ratio | 1.46x | 3.94x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Audit opinion
- Unaudited (audit-exempt)
Significant events
- “No political contributions were made by the Company in the year ended 31 December 2025 (2024: Nil).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-06-15 | — | — |
| ENRIGHT, William James | Director | 2019-10-03 | Oct 1962 | American |
| HAMMACHER, Alexander Eric | Director | 2020-07-21 | Dec 1980 | British |
| OLSSON, Paer Ragnar, Dr | Director | 2025-11-23 | Mar 1967 | Swedish |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| EVANS, Thomas | Director | 2018-11-01 | 2020-07-17 |
| MCLEAN, Andrew James, Dr | Director | 2019-10-03 | 2019-12-20 |
| MCLEAN, Andrew James, Dr | Director | 2018-11-01 | 2019-10-03 |
| SKIPPER, Jonathan Charles Alexander | Director | 2019-01-22 | 2025-11-23 |
| HUNTSMOOR LIMITED | Corporate Director | 2018-11-01 | 2018-11-01 |
| HUNTSMOOR NOMINEES LIMITED | Corporate Director | 2018-11-01 | 2018-11-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Barinthus Biotherapeutics (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-11-01 | Active |
Filing timeline
Last 20 of 47 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-25 | AAMD | accounts | Accounts amended with accounts type full | |
| 2026-04-13 | AA | accounts | Accounts with accounts type total exemption full | |
| 2026-02-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-24 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2025-11-25 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-25 | AP01 | officers | Appoint person director company with name date | |
| 2025-06-27 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-06-27 | AD04 | address | Move registers to registered office company with new address | |
| 2025-06-27 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-05-16 | AA | accounts | Accounts with accounts type full | |
| 2025-02-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-05-31 | AA | accounts | Accounts with accounts type full | |
| 2024-04-10 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2024-02-02 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-11-09 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-08-08 | AA | accounts | Accounts with accounts type full | |
| 2023-02-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-07 | AA | accounts | Accounts with accounts type full | |
| 2022-07-01 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-07-01 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.